Sunshine Biopharma Inc.
SBFM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001402328
No open-market purchases or sales by Sunshine Biopharma Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $32.6K in total; no superinvestor holds it.
Other share classesSBFMW
13F holders, Q2 2024
Institutional positions in Sunshine Biopharma Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- −4 vs. Q1 2024
- Shares held
- 216.6K
- −5.51M (−96.2%) vs. Q1 2024
- Total value
- $89.6K
- −$256.6K (−74.1%) vs. Q1 2024
- New holders
- 5
- 1 more added
- Sold out
- 9
- 4 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SBFM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 9 | $32.6K |
| Q1 2026 | 12 | $127.1K |
| Q4 2025 | 13 | $141.7K |
| Q3 2025 | 14 | $337.3K |
| Q2 2025 | 12 | $187.2K |
| Q1 2025 | 11 | $151.7K |
| Q4 2024 | 12 | $61.8K |
| Q3 2024 | 10 | $111.3K |
| Q2 2024 | 11 | $89.6K |
| Q1 2024 | 15 | $346.2K |
| Q4 2023 | 15 | $745.7K |
| Q3 2023 | 11 | $415.1K |
| Q2 2023 | 10 | $1.25M |
| Q1 2023 | 13 | $292.4K |
| Q4 2022 | 12 | $261.8K |
| Q3 2022 | 12 | $341.1K |
| Q2 2022 | 18 | $802.1K |
| Q1 2022 | 13 | $3.55M |
| Q4 2021 | 1 | $17.0K |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Sunshine Biopharma Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Susquehanna International Group, LLP | 76,967 | $32.1K | 0.00% | +76,967 | New |
| XTX Topco Ltd | 44,008 | $18.4K | 0.00% | −9,714−18.1% | Reduced |
| HRT Financial LP | 45,022 | $18.0K | 0.00% | +26,954+149.2% | Added |
| Jane Street Group, LLC | 27,856 | $11.6K | 0.00% | −59,754−68.2% | Reduced |
| Sabby Management, LLC | 20,000 | $8.35K | 0.11% | +20,000 | New |
| Qube Research & Technologies Ltd | 1,529 | $638 | 0.00% | +1,529 | New |
| Morgan Stanley | 1,000 | $418 | 0.00% | +1,000 | New |
| Bank of America Corp | 100 | $42 | 0.00% | −9,900−99.0% | Reduced |
| National Bank of Canada | 65 | $26 | 0.00% | +65 | New |
| Main Street Group, LTD | 3 | $1 | 0.00% | −219−98.6% | Reduced |
| UBS Group AG | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −4,610,900−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −550,514−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −286,100−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −65,000−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −20,179−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −19,196−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −79−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −68−100.0% | Sold out |
| Rise Advisors, LLC | 0 | $0 | 0.00% | −18−100.0% | Sold out |